Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InspireMD (NSPR) Gross Profit (2016 - 2025)

InspireMD's Gross Profit history spans 16 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 151.6% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $2.6 million, up 75.9%, while the annual FY2025 figure was $2.6 million, 75.9% up from the prior year.
  • Gross Profit reached $1.2 million in Q4 2025 per NSPR's latest filing, up from $864000.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $1.2 million in Q4 2025 to a low of $92000.0 in Q3 2021.
  • Average Gross Profit over 5 years is $391650.0, with a median of $348500.0 recorded in 2022.
  • The largest YoY upside for Gross Profit was 318.33% in 2021 against a maximum downside of 69.13% in 2021.
  • A 5-year view of Gross Profit shows it stood at $294000.0 in 2021, then crashed by 32.65% to $198000.0 in 2022, then soared by 155.05% to $505000.0 in 2023, then fell by 7.13% to $469000.0 in 2024, then skyrocketed by 151.6% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Gross Profit are $1.2 million (Q4 2025), $864000.0 (Q3 2025), and $313000.0 (Q2 2025).